Stocksigma LogoStocksigma Logo

Trident Texofab Schedules Board Meeting to Approve Q2 Results

Trident Texofab Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone financial results for the

Trident Texofab Schedules Board Meeting to Approve Q2 Results

Trident Texofab Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Trident Texofab Schedules Board Meeting to Approve Q2 Results Trident Texofab Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for the company's equity shares, which closed on 1st Oct'26, will reopen 48 hours after the financial results are made public.

Original exchange filing (PDF)

More announcements from Trident Texofab Ltd

All Trident Texofab Ltd announcements